Interv Akut Kardiol. 2019;18(2):102-104 | DOI: 10.36290/kar.2019.028

Outpatient treatment options for pulmonary embolism

Radovan Malý1,2, Tomáš Veleta3, Martina Čermáková4
I. interní kardioangiologická klinika, Fakultní nemocnice Hradec Králové, Lékařská fakulta Univerzity Karlovy
1 v Hradci Králové
2 Ústav ošetřovatelství, Fakulta veřejných politik v Opavě, Slezská Univerzita Opava
3 Oddělení urgentní medicíny, Fakultní nemocnice Hradec Králové, Lékařská fakulta Univerzity Karlovy v Hradci Králové
4 Lékařská fakulta Univerzity Karlovy v Hradci Králové

Pulmonary embolism (PE) is a serious and sometimes even fatal complication of venous thromboembolism (VTE). PE is typically managed in hospital, although a number of PE patients who are at a low risk of complications can be treated at home. It is assumed that up to 50% of PE patients who are at a low risk of death can be candidates for an early discharge or for staying at home. Despite this fact, the reality is completely different, with most individuals diagnosed with acute PE being treated in hospital. When treated at home, carefully selected low-risk PE patients have at least an equally good, if not better, prognosis compared with those who are treated in hospital. The selection of patients for outpatient PE treatment should, in routine practice, include the PESI or sPESI criteria supplemented by the Hestia exclusion criteria, and/or the European Society of Cardiology (ESC) criteria for the treatment of acute PE. Direct oral anticoagulants are proving to be a very effective option for the home treatment of PE. Outpatient treatment of low-risk PE patients may potentially reduce the health care costs associated with PE treatment.

Keywords: pulmonary embolism, venous thromboembolism, home treatment, risk stratification, anticoagulants

Published: May 2, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Malý R, Veleta T, Čermáková M. Outpatient treatment options for pulmonary embolism. Interv Akut Kardiol. 2019;18(2):102-104. doi: 10.36290/kar.2019.028.
Download citation

References

  1. Raskob GE, Angchaisuksiri P, Blanco AN, et al. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014; 34: 2363-2371. Go to original source... Go to PubMed...
  2. Karetová D, Chochola M. Vaskulární medicína. Praha: Maxdorf, (2017). Jessenius.
  3. Cohen AT, Agnelli G, Anderson FA, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764. Go to original source...
  4. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033-3069. Go to original source... Go to PubMed...
  5. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149: 315-352. Go to original source... Go to PubMed...
  6. Jiménez D, Aujesky D, Moores L, et al. Simplification of the Pulmonary Embolism Severity Index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170: 1383-1389. Go to original source... Go to PubMed...
  7. Howard L, Barden S, Condliffe R, et al. British Thoracic Society guideline for the initial outpatient management of pulmonary embolism (PE). Thorax 2018; 73: ii1-ii29. Go to original source...
  8. Jiménez D, de Miguel-Díez J, Guijarro R, et al. RIETE Investigators. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J Am Coll Cardiol 2016; 67: 162-170. Go to original source... Go to PubMed...
  9. Stein PD, Matta F, Hughes MJ. National trends in home treatment of acute pulmonary embolism. Clin Appl Thromb Hemost 2018; 24: 115-121. Go to original source... Go to PubMed...
  10. Dentali F, Di Micco G, Giorgi Pierfranceschi M, et al. Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice. Ann Med 2015; 47: 546-554. Go to original source... Go to PubMed...
  11. ÚZIS: Zdravotnická statistika - hospitalizovaní. Dostupné z: http://www.uzis.cz/katalog/zdravotnicka-statistika/hospitalizovani.
  12. Becattini C, Agnelli G, Lankeit M, et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J. 2016; 48: 780-786. Go to original source... Go to PubMed...
  13. Otero R, Uresandi F, Jiménez D, et al. Home treatment in pulmonary embolism. Thromb Res 2010; 126: e1-e5. Go to original source... Go to PubMed...
  14. Righini M, Roy PM, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost. 2011: 2115-2117. Go to original source... Go to PubMed...
  15. Zondag W, Mos IC, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011; 9: 1500-1507. Go to original source... Go to PubMed...
  16. Zondag W, den Exter PL, Crobach MJ, et al.; on behalf of The Hestia Study Investigators. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost 2013; 109: 47-52. Go to original source... Go to PubMed...
  17. Quezada CA, Bikdeli B, Villen T, et al. Accuracy and interobserver reliability of the Simplified Pulmonary Embolism Severity Index versus the Hestia criteria for patients with pulmonary embolism. Acad Emerg Med 2018: doi:10.1111/acem.13561. Go to original source... Go to PubMed...
  18. Wang L, Baser O, Wells P, et al. Benefit of early discharge among patients with low-risk pulmonary embolism. PLoS One 2017; 12: e0185022. Go to original source... Go to PubMed...
  19. Li A, Garcia DA, Lyman GH, Carrier M. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis. Thromb Res 2018: doi:10.1016/j.thromres.2018.02.144. Go to original source... Go to PubMed...
  20. Khorana AA, Noble S, Lee AYY, et al. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost 2018; 16: 1891-1894. Go to original source... Go to PubMed...
  21. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011; 378: 41-48. Go to original source... Go to PubMed...
  22. Walen S, Katerberg B, Boomsma MF, van den Berg JWK. Safety, feasibility and patient reported outcome measures of outpatient treatment of pulmonary embolism. Thromb Res 2017; 156: 172-176. Go to original source... Go to PubMed...
  23. Ghazvinian R, Gottsater A, Elf JL. Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism. J Thromb Thrombolysis 2018; 45: 319-324. Go to original source... Go to PubMed...
  24. Bledsoe JR, Woller SC, Stevens SM, et al. Management of low-risk pulmonary embolism patients without hospitalization: the Low-Risk Pulmonary Embolism prospective management study. Chest 2018; 154: 249-256. Go to original source... Go to PubMed...
  25. Malý R, Malý J. Outpatient treatment of venous thromboembolic disease. Vnitr Lek. 2015; 61: 431-438. Go to PubMed...
  26. Peacock WF, Singer AJ. Reducing the hospital burden associated with the treatment of pulmonary embolism. J Thromb Haemost 2019; https://doi:10.1111/jth.14423. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.